...
首页> 外文期刊>Progress in Cardiovascular Diseases >Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy.
【24h】

Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy.

机译:心律失常性右室心肌病/发育不良:危险分层和治疗。

获取原文
获取原文并翻译 | 示例

摘要

Arrhythmogenic right ventricular cardiomyo-pathy/dysplasia (ARVC/D) is an inherited heart muscle disease that occurs primarily in young and middle-aged individuals. It is characterized by ventricular arrhythmias (VA), sudden death, and heart failure occurring later in life. Ventricular electrical instability may occur at any time during the disease depending upon possible different pathophysiologic mechanisms including (a) inflammation and apoptosis leading to ventricular fibrillation or (b) fibrofatty tissue repair leading to scar-related ventricular tachycardia (VT). Heart failure may occur later in life secondary to slow, progressive loss of right and left ventricular myocardium.
机译:心律失常性右室心肌病/异型增生(ARVC / D)是一种遗传性心肌病,主要发生在年轻人和中年人中。它的特征是室性心律不齐(VA),猝死和晚年发生心力衰竭。根据可能的不同病理生理机制,在疾病期间的任何时间都可能发生心室电不稳定性,包括(a)导致心室纤颤的炎症和细胞凋亡或(b)导致疤痕相关性心动过速(VT)的纤维脂肪组织修复。心力衰竭可能发生在生命的后期,继发于左右心室心肌缓慢,进行性丧失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号